Published February 3, 2023
| Version v1
Journal article
Open
Neuropsychiatry and COVID-19: An Overview
Creators
- 1. Department of Neurology, University Hospital Marqués de Valdecilla, Ceuta, Spain
- 2. Department of Education, International University of La Rioja (UNIR), Madrid, Spain
- 3. Department of Neuropsychology, Private Practice of Neuropsychology, HC Marbella, Ceuta, Spain
- 4. Department of Psychologist at Ability, University Hospital Marqués de Valdecilla, Ceuta, Spain
- 5. Department of Psychologist, Concentra Center, Ceuta, Spain
Description
Most of studies that exist on the COVID-19 pandemic produced by the SARS-CoV-2 coronavirus, report neuropsychiatric symptoms only as part of the manifestation of the disease in its terminal phase. However, there are neuropsychiatric symptoms since the beginning of the disease. Several investigations have indicated a direct relationship between chronic diseases such as Human Immunodeficiency Virus (HIV), tuberculosis, SARS, MERS, Ebola and SARS 2003 with mental disorders such as depression. Neuropsychiatric disorders can occur due to different mechanisms, such as cerebral hypoxia, cytokine storm due to exaggerated immune response and encephalitis due to direct brain infection. Nervous system involvement leads to poor prognosis of COVID-19.
Files
neuropsychiatry-and-covid19-an-overview.pdf.pdf
Files
(770.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:fbe1850af9327da1820a86d9ab94c990
|
770.0 kB | Preview Download |